A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

Source:http://linkedlifedata.com/resource/pubmed/id/20696678

Download in:

View as

General Info

PMID
20696678